Hypervision, a pioneer in real-time hyperspectral imaging for surgery, announced the successful closing of its oversubscribed £17m Series A financing round, led by Heal Capital with participation from Angelini Ventures, IP Group, and Daycrest.
Read moreHypervision Surgical is proud to announce that we have been awarded the 2025 Lippmann Award, a global distinction recognising impactful innovation in hyperspectral imaging.
Read moreWhen Life Science Intelligence (LSI) launched its first LSI Europe conference in London in 2022, it marked an inflection point for Hypervision Surgical.
Read moreHypervision secured 2nd place at the 2025 SRS Shark Tank, spotlighting its breakthrough AI-powered spectral imaging platform at the world’s leading digital surgery and robotics forum.
Read moreHypervision Surgical (“Hypervision”), a King’s College London spin-out pioneering the next generation of intraoperative imaging, is accelerating its mission to transform surgical decision-making.
Read moreHypervision Surgical (“Hypervision”) proudly announces that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the HYPERSNAP® Surgical System — the first intraoperative platform to combine Hyperspectral Imaging (HSI) with AI-powered analytics for real-time surgical decision support.
Read more
